NCT05915884View on ClinicalTrials.gov

The Triglyceride/Glucose Index and SGLT-2 Inhibitors

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

June 10, 2023

Primary Completion Date

October 28, 2023

Study Completion Date

January 28, 2024

Conditions
Metabolic DiseaseDiabetes
Interventions
OTHER

SGLT-2 inhibitors

This study is an observational study. It is not planned to do an interventional activity.

Trial Locations (1)

55200

Samsun Education and Research Hospital, Samsun

All Listed Sponsors
lead

Samsun Education and Research Hospital

OTHER

NCT05915884 - The Triglyceride/Glucose Index and SGLT-2 Inhibitors | Biotech Hunter | Biotech Hunter